Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Pathology

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/AJPATH.2006.060143PMID 17071591PMCID PMC1780210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis.

  2006cited by this paper
• Toll‐like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia

  2005cited by this paper
• TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1

  2005cited by this paper
• CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance

  2005cited by this paper
• Faculty Opinions recommendation of Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.

  2005cited by this paper
• Identification of serum N-acetylmuramoyl-l-alanine amidase as liver peptidoglycan recognition protein 2.

  2005cited by this paper
• Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease

  2005influential reference
• Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis

  2005cited by this paper
• Suppression of Ongoing Disease in a Nonhuman Primate Model of Multiple Sclerosis by a Human-Anti-Human IL-12p40 Antibody1

  2005cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005influential reference
• Toll‐like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin‐12 production in response to internalized bacteria

  2004cited by this paper
• Autoreactive T Cells Persist in Rats Protected against Experimental Autoimmune Encephalomyelitis and Can Be Activated through Stimulation of Innate Immunity1

  2004cited by this paper
• Innate Immune Responses in Peptidoglycan Recognition Protein L-Deficient Mice

  2004cited by this paper
• Ultrastructural immunocytochemical localization of lysozyme in human monocytes and macrophages

  2004cited by this paper
• S. aureus‐dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15‐deoxy‐Δ12,14‐ prostaglandin J2 (15d‐PGJ2)

  2004cited by this paper
• Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease.

  2004cited by this paper
• Loss of macrophage-secreted lysozyme in HIV-1-associated dementia detected by SELDI-TOF mass spectrometry

  2004cited by this paper
• Nods and 'intracellular' innate immunity.

  2004cited by this paper
• Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria

  2004cited by this paper
• The Third Signal in T Cell-Mediated Autoimmune Disease?1

  2004cited by this paper
• Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition

  2004cited by this paper
• Modelling of multiple sclerosis: lessons learned in a non-human primate.

  2004cited by this paper
• Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1

  2004cited by this paper
• Induction of tolerogenic DCs: 'you are what you eat'.

  2003cited by this paper
• Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase*

  2003cited by this paper
• Tertiary Structure of Bacterial Murein: the Scaffold Model

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Toll‐like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram‐positive bacterium Staphylococcus aureus

  2003cited by this paper
• A mammalian peptidoglycan recognition protein with N-acetylmuramoyl-L-alanine amidase activity.

  2003cited by this paper
• An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems 1

  2003cited by this paper
• Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2*

  2003cited by this paper
• Broad Expression of Toll‐Like Receptors in the Human Central Nervous System

  2002cited by this paper
• Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

  2002cited by this paper
• Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease1

  2002cited by this paper
• Intracellular vs extracellular recognition of pathogens--common concepts in mammals and flies.

  2002cited by this paper
• Prevention of Experimental Autoimmune Encephalomyelitis in Common Marmosets Using an Anti-IL-12p40 Monoclonal Antibody1

  2002cited by this paper
• Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.

  2002cited by this paper
• Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression.

  2002cited by this paper
• Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

  2001cited by this paper
• Enzyme Degradation and Proinflammatory Activity in Arthritogenic and Nonarthritogenic Eubacterium aerofaciens Cell Walls

  2001cited by this paper
• The Role of Toll-like Receptors (TLRs) in Bacteria-induced Maturation of Murine Dendritic Cells (DCs)

  2001cited by this paper
• Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects.

  2001cited by this paper
• Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis.

  2001influential reference
• An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin.

  2001cited by this paper
• Non‐human primate models of multiple sclerosis

  2001influential reference
• Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates

  2001cited by this paper
• Induction of Type 1 Immune Pathology in the Brain Following Immunization Without Central Nervous System Autoantigen in Transgenic Mice With Astrocyte-Targeted Expression of IL-121

  2001cited by this paper
• Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS

  2000cited by this paper
• Role of Antigen-Presenting Cells in Mediating Tolerance and Autoimmunity

  2000cited by this paper
• Pathologic Role and Temporal Appearance of Newly Emerging Autoepitopes in Relapsing Experimental Autoimmune Encephalomyelitis1

  2000cited by this paper
• Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines.

  2000cited by this paper
• Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes.

  2000cited by this paper
• Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and Endotoxin*

  2000cited by this paper
• Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule1

  2000cited by this paper
• A new primate model for multiple sclerosis in the common marmoset.

  2000influential reference
• The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens

  1999cited by this paper
• Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability

  1999cited by this paper
• Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells.

  1999cited by this paper
• The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens

  1999cited by this paper
• Production of Interleukin-12 by Murine Macrophages in Response to Bacterial Peptidoglycan

  1998cited by this paper
• Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).

  1998cited by this paper
• Differences in N-acetylmuramyl-L-alanine amidase and lysozyme in serum and cerebrospinal fluid of patients with bacterial meningitis.

  1998cited by this paper
• Antigen sampling by epithelial tissues: implication for vaccine design.

  1997cited by this paper
• Inflammatory properties of peptidoglycan are decreased after degradation by human N-acetylmuramyl-L-alanine amidase.

  1997cited by this paper
• Expression and intracellular localization of the human N-acetylmuramyl-L-alanine amidase, a bacterial cell wall-degrading enzyme.

  1997cited by this paper
• Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques.

  1997cited by this paper
• Animal models of intestinal and joint inflammation.

  1996cited by this paper
• Purification and characterization of N-acetylmuramyl-L-alanine amidase from human plasma using monoclonal antibodies.

  1996cited by this paper
• Presence of bacterial flora-derived antigen in synovial tissue macrophages and dendritic cells.

  1995cited by this paper
• Evolution of Major Histocompatibility Complex Polymorphisms and T‐Cell Receptor Diversity in Primates

  1995cited by this paper
• Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

  1995cited by this paper
• Muramic acid in peripheral blood leukocytes of healthy human subjects.

  1995cited by this paper
• Phenotypic Differences between Human Monocytes/Macrophages and Microglial Cells Studied In Situ and In Vitro

  1994cited by this paper
• Isolation of peptidoglycan and soluble peptidoglycan fragments.

  1994cited by this paper
• Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats.

  1994influential reference
• The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease.

  1994cited by this paper
• Pharmacokinetics of an immunomodulator peptidoglycan monomer in mice after intravenous administration.

  1993cited by this paper
• Induction of Acute Arthritis in Mice by Peptidoglycan Derived from Gram‐Positive Bacteria and Its Possible Role in Cytokine Production

  1993cited by this paper
• Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region

  1992cited by this paper
• Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals

  1990cited by this paper
• Combination of diaminobenzidine staining and immunogold labeling: a novel technical approach to identify lysozyme in human neutrophil cells.

  1989cited by this paper
• Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis.

  1989cited by this paper
• Elimination of group A streptococcal cell walls from mammalian tissues

  1987cited by this paper
• Intestinal absorption of bacterial cell wall polymers in rats.

  1987cited by this paper
• Müllerian aplasia associated with maternal deficiency of galactose-1-phosphate uridyl transferase.

  1987cited by this paper
• Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci

  1986cited by this paper

• Peripheral HLA-DRhiCD141+ Classical Monocytes Predict Relapse Risk and Worsening in Multiple Sclerosis

  2025cites this paper
• Evolutionary insights into Interleukin-12 family targets across 405 species

  2025cites this paper
• Current advances on RIPK2 and its inhibitors in pathological processes: a comprehensive review

  2025cites this paper
• Role of the intestinal microbiota in the pathogenesis of multiple sclerosis. Part 3. Gut microbiota as a potential trigger for multiple sclerosis

  2024cites this paper
• Ripks and Neuroinflammation

  2024cites this paper
• In Vitro and Ex Vivo Methodologies for T-Cell Trafficking Through Blood-Brain Barrier After TLR Activation.

  2023cites this paper
• How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation

  2022influential citation
• A novel bioactive postbiotics: from microbiota-derived extracellular nanoparticles to health promoting

  2022cites this paper
• Association of PGLYRP2 gene polymorphism and sporadic Parkinson's disease in northern Chinese Han population.

  2022cites this paper
• The Inflammatory Conspiracy in Multiple Sclerosis: A Crossroads of Clues and Insights through Mast Cells, Platelets, Inflammation, Gut Microbiota, Mood Disorders and Stem Cells

  2022cites this paper
• Spinal fluid antibodies against multiple sclerosis candidate bacteria in demyelinating disease

  2021cites this paper
• A peptidoglycan storm caused by β-lactam antibiotic’s action on host microbiota drives Candida albicans infection

  2021cites this paper
• Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication

  2021cites this paper
• Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria

  2021cites this paper
• Sensory neuron–associated macrophages as novel modulators of neuropathic pain

  2021cites this paper
• NOD1 and NOD2 in inflammatory and infectious diseases

  2020cites this paper
• Bacterial Peptidoglycan as a Driver of Chronic Brain Inflammation.

  2020influential citation
• Spectrum of Microbial Sequences and a Bacterial Cell Wall Antigen in Primary Demyelination Brain Specimens Obtained from Living Patients

  2019cites this paper
• Leukemia inhibitory factor inhibits erythropoietin-induced myelin gene expression in oligodendrocytes

  2018cites this paper
• Impacts of microbiome metabolites on immune regulation and autoimmunity

  2018cites this paper
• The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development

  2018cites this paper
• University of Groningen Modulation of Multiple Sclerosis and its Animal Model experimental Autoimmune encephalomyelitis by Food and Gut Microbiota

  2017cites this paper
• Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota

  2017cites this paper
• University of Groningen Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis

  2017cites this paper
• Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis

  2016cites this paper
• Gram-negative bacterial molecules associate with Alzheimer disease pathology

  2016cites this paper
• Immunology of Central Nervous System Pathogens

  2016cites this paper
• Functional genomics of human brain development and implications for autism spectrum disorders

  2015cites this paper
• The role of T cell subsets in experimental autoimmune encephalomyelitis

  2015cites this paper
• Abundant kif21b is associated with accelerated progression in neurodegenerative diseases

  2014cites this paper
• Microbial view of central nervous system autoimmunity

  2014cites this paper
• Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients.

  2014cites this paper
• The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes

  2014cites this paper
• The potential pathogenicity of Dolosigranulum pigrum in multiple sclerosis, and the occurrence of the organism in the upper respiratory tract

  2014cites this paper
• by Different TLR Ligands Triggered Pathogenic Autoimmune Processes Differential Involvement of Th1 and Th17 in

  2014cites this paper
• Role of Macrophages in the Pathogenesis of Atopic Dermatitis

  2013cites this paper
• Role of toll-like receptors in multiple sclerosis.

  2013cites this paper
• The Role of Toll-Like Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

  2013cites this paper
• Brain Microbial Populations in HIV/AIDS: α-Proteobacteria Predominate Independent of Host Immune Status

  2013cites this paper
• Innate Immune Responses in the CNS: Role of Toll-Like Receptors, Mechanisms, and Therapeutic Opportunities in Multiple Sclerosis

  2013cites this paper
• Differential Involvement of Th1 and Th17 in Pathogenic Autoimmune Processes Triggered by Different TLR Ligands

  2013cites this paper
• 1 TLR-dependent T cell activation in autoimmunity

  2012cites this paper
• Adaptive Immune Response in Epilepsy

  2012cites this paper
• Retinal Astrocytes Pretreated with NOD2 and TLR2 Ligands Activate Uveitogenic T Cells

  2012cites this paper
• Involvement of IL-1R/TLR signalling in experimental autoimmune encephalomyelitis and multiple sclerosis.

  2012cites this paper
• Expression of Toll-Like Receptors in the Developing Brain

  2012cites this paper
• Toll-like receptor (TLR) and inflammasome actions in the central nervous system.

  2012cites this paper
• TLR2 and TLR4 Gene Polymorphisms and Atopic Dermatitis in Italian Children: A Multicenter Study

  2011cites this paper
• Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity.

  2011cites this paper
• Regulation of innate immune responses in the central nervous system.

  2011cites this paper
• TLR-dependent T cell activation in autoimmunity

  2011cites this paper
• Functional effects of interleukin 31 in human primary keratinocytes

  2011cites this paper
• Toll-like receptors in inflammation of the central nervous system.

  2011cites this paper
• Intrinsic alterations of pro‐inflammatory mediators in unstimulated and TLR‐2 stimulated keratinocytes from atopic dermatitis patients

  2011cites this paper
• Peptidoglycan: a critical activator of the mammalian immune system during infection and homeostasis

  2011cites this paper
• Innate immunity, allergy and atopic dermatitis

  2010cites this paper
• TLR‐2‐mediated cytokine and chemokine secretion in human keratinocytes

  2010cites this paper
• The Role of the Toll-Like Receptors in Neuropathology

  2010cites this paper
• Exploring the molecular basis to the regulatory effects of Cannabinoids on toll-like receptor signalling

  2010cites this paper
• The role of toll-like receptors in chronic inflammation.

  2010cites this paper
• Inflammation in neurodegenerative diseases

  2010cites this paper
• Mycobacteria-Induced Suppression of Autoimmunity in the Central Nervous System

  2010cites this paper
• Immune-mediated CNS damage.

  2010cites this paper
• Impaired TLR‐2 expression and TLR‐2‐mediated cytokine secretion in macrophages from patients with atopic dermatitis

  2009cites this paper
• Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE

  2009cites this paper
• Clinical, Pathological, and Immunologic Aspects of the Multiple Sclerosis Model in Common Marmosets (Callithrix jacchus)

  2009cites this paper
• Toll-like receptors in multiple sclerosis.

  2009cites this paper
• Dysregulation of toll‐like receptor‐2 (TLR‐2)‐induced effects in monocytes from patients with atopic dermatitis: impact of the TLR‐2 R753Q polymorphism

  2008cites this paper
• Role of the innate immune system in autoimmune inflammatory demyelination.

  2008cites this paper
• Autoimmunity to Neuronal Antigens in Multiple Sclerosis

  2008cites this paper
• Targeting intracellular signaling: a novel approach to vaccination

  2007cites this paper